NEUP

Neuphoria Therapeutics Inc (NEUP)

US
$ 3.493.24%

Price Chart

Key Statistics

Market Cap
$ 96.47M
P/E Ratio
0.45
Revenue (TTM)
$ 662.72K
Volume
35.38K
52W High
$ 11.28
52W Low
$ 2.12
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
3.9429
200-Day MA
6.4742
52 Week High
11.28
52 Week Low
2.124

About NEUP

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Employees
8
Headquarters
Burlington, MA
CEO
Dr. Spyridon Papapetropoulos M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg